Teva ANASTROZOLE 28tab 1mg/tab

Description

Manufacturer: Teva

Anastrozole, developed by Zeneca Pharmaceuticals, is an oral aromatase inhibitor hailed for its efficacy. FDA-approved in late 1995, Anastrozole (Arimidex) is categorized as a non-steroidal Type II inhibitor, exerting reversible competitive inhibition on the enzyme. Unlike Type I inhibitors, which form a permanent bond with the aromatase enzyme complex, Anastrozole's mechanism allows for restoration of normal enzyme function upon drug clearance.

Primarily utilized in the treatment of breast and ovarian cancer in postmenopausal women, aromatase inhibitors (AI) have garnered attention among bodybuilders seeking to mitigate estrogenic side effects during anabolic steroid cycles. By halting the conversion of androgens to estrogens, Anastrozole effectively reduces the risk of gynecomastia and water retention. Athletes favor Anastrozole for its potency, with daily doses ranging from 0.5 mg to 1 mg yielding a significant reduction in serum estradiol levels, typically by 50% in men. In most cycles, a dosage of 1 mg suffices to maintain estrogen levels within optimal bounds.

While Anastrozole offers notable benefits, its use may entail certain side effects, including nausea, vomiting, hot flashes, joint pain, weakness, fatigue, mood changes, depression, elevated blood pressure, and headaches. Prolonged usage may also decrease bone mineral density, potentially leading to osteoporosis. Extended periods of low estrogen levels may contribute to cardiovascular complications and immune system alterations. As a precautionary measure, usage should not exceed two months to minimize associated risks.